name | 祝鸿俊 |
sex | male
|
age | 84 岁 |
hospital number | 189380 |
height | 170 cm |
weight | 70 kg |
BSA | 1.81 m2 |
APACHEⅡ | 30 分 |
Infection source | lung
/urinary
/blood
/skin and soft tissue
|
date | 2017/11/21 年/月/日 |
Sequential Organ Failure Assessment | 13 分 |
Fluid resuscitation | CVP8-12 mmHg
/MAP≥65 mmHg
/ScvO2≥70%
|
age>=60 | yes
|
septic shock | yes
|
mechanical ventilation | trachea cannula
|
Early fluid resuscitation | yes
|
age<60 | no
|
Pregnant woman | no
|
advanced malignant tumor | no
|
Pulmonary interstitial fibrosis | no
|
Serious arrhythmia | no
|
Small Tidal Volume Ventilation | no
|
Liver failure | no
|
Refuse to participate | no
|
Heart disease | coronary atherosclerotic cardiopathy
|
yes
|
|
no
|
|
no
|
|
yes
|
|
no
|
- vital signs
- Blood Gas Analysis
- vasoactive agent and fluid
- PiCCO parameters
- Cardiac Ultrasound
- lung ultrasound
- inferior vena cava
yes
|
|
舒普深 2.0 q6h |
|
vasoactive agent | norepinephrine
|
30 min |
|
min |
|
43200 min |
Temperature | 38 ℃ |
Heart Rate | 108 次/分 |
Breath | 17 次/分 |
Systolic pressure (SP) | 130 mmHg |
Diastolic pressure | 78 mmHg |
mean arterial pressure | 95 mmHg |
Pcv-aCO2 | 8 mmHg |
DO2 | 444.6 |
VO2 | 161.0 |
Ca-vO2 | 34.6 |
pH value | 7.46 |
PaO2 | 160 mmHg |
PaCO2 | 30 mmHg |
BE | -2.1 mmol/L(±2.3mmol/L) |
SaO2 | 100 % |
Blood lactic acid concentration, LAC | 1.9 mmol/L |
Oxygenation index (PaO2/FiO2) | 400 mmHg |
pH value | 7.35 |
PcvO2 | 34 mmHg |
PcvCO2 | 38 mmHg |
BE | -4.2 mmol/L |
ScvO2 | 64 % |
Volume of input | 0 ml |
Volume of output | 0 ml |
Volume of urine | 0 ml |
ultrafiltration volume | 0 ml |
norepinephrine | yes
|
Norepinephrine Dosage | 10 μg/Kg/min |
dopamine | no
|
Dopamine Dosage | μg/Kg/min |
Dobutamine | No
|
Dobutamine Dosage | μg/Kg/min |
CVP | 11 mmHg |
cardiac output | 4.65 L/min |
cardiac index | 2.57 L/min/m2 |
stroke volume | 48.2 ml |
Stroke Index | 26.6 ml/m2 |
ITBVI | 936 ml/m2 |
GEDVI | 748 ml/m2 |
EVLWI | 7.1 ml/kg |
PVPI | 1.4 |
SVRI | 1200 DSm2/cm5 |
CFI | 4.8 |
GEF | 15 % |
SVV | 13 % |
PPV | % |
dPmax | 1235 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
the number of B line | 16 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 2.4 mm |
IVC(expiratory phase) | 2.5 mm |
respiratory variations of inferior vena cavae diameter | 4 % |
2.3 mm |
|
mm |
|
2.4 mm |
|
mm |
- Inferior Vena Cava
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
IVC(inspiratory phase) | 2.2 mm |
IVC(expiratory phase) | 2.4 mm |
Respiratory variations of inferior vena cavae diameter | 8 % |
2.0 mm |
|
mm |
|
2.3 mm |
|
mm |
Temperature | 37.8 ℃ |
Heart Rate | 112 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 135 mmHg |
Diastolic Pressure | 65 mmHg |
Mean Arterial Pressure | 88 mmHg |
Pcv-aCO2 | 8 mmHg |
DO2 | 506.7 |
VO2 | 137.9 |
Ca-vO2 | 26.0 |
PH value | 7.43 |
PaO2 | 152 mmHg |
PaCO2 | 34 mmHg |
BE | -0.8 mmol/L |
SaO2 | 100 % |
Blood Lactic Acid Concentration | 1.6 mmol/L |
Oxygenation index (PaO2/FiO2) | 380 mmHg |
PH value | 7.36 |
PcvO2 | 39 mmHg |
PcvCO2 | 42 mmHg |
BE | -1.3 mmol/L |
ScvO2 | 73 % |
Volume of input | 2028 ml |
Volume of output | 300 ml |
Volume of urine | 300 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 8.6 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 13 mmHg |
cardiac output | 5.3 L/min |
cardiac index | 2.96 L/min/m2 |
stroke volume | 53.1 ml |
Stroke Index | 29.2 ml/m2 |
ITBVI | 975 ml/m2 |
GEDVI | 780 ml/m2 |
EVLWI | 7.3 ml/kg |
PVPI | 1.6 |
SVRI | 1600 DSm2/cm5 |
CFI | 5.0 |
GEF | 14 % |
SVV | 11 % |
PPV | % |
dPmax | 1240 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 18 条 |
LUS | 分 |
B+ Zone | 区 |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.5 ℃ |
Heart Rate | 95 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 128 mmHg |
Diastolic Pressure | 63 mmHg |
Mean Arterial Pressure | 84 mmHg |
Pcv-aCO2 | 8 mmHg |
DO2 | 506.7 |
VO2 | 137.9 |
Ca-vO2 | 26.0 |
PH value | 7.41 |
PaO2 | 111 mmHg |
PaCO2 | 35 mmHg |
BE | -2.1 mmol/L |
SaO2 | 98 % |
Blood Lactic Acid Concentration | 1.3 mmol/L |
Oxygenation index (PaO2/FiO2) | 277.5 mmHg |
PH value | 7.31 |
PcvO2 | 38 mmHg |
PcvCO2 | 43 mmHg |
BE | -6.3 mmol/L |
ScvO2 | 75 % |
Volume of input | 4056 ml |
Volume of output | 600 ml |
Volume of urine | 600 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 24 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan |
CVP | 13 mmHg |
cardiac output | 5.73 L/min |
cardiac index | 3.16 L/min/m2 |
stroke volume | 61.5 ml |
Stroke Index | 33.9 ml/m2 |
ITBVI | 900 ml/m2 |
GEDVI | 720 ml/m2 |
EVLWI | 7.1 ml/kg |
PVPI | 1.6 |
SVRI | 1820 DSm2/cm5 |
CFI | 4.9 |
GEF | 16 % |
SVV | 10 % |
PPV | % |
dPmax | 1360 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 14 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 2.0 mm |
IVC(expiratory phase) | 2.4 mm |
Respiratory variations of inferior vena cavae diameter | 18 % |
1.8 mm |
|
mm |
|
2.2 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.8 ℃ |
Heart Rate | 81 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 139 mmHg |
Diastolic Pressure | 80 mmHg |
Mean Arterial Pressure | 99 mmHg |
Pcv-aCO2 | 9 mmHg |
DO2 | 60.3.3 |
VO2 | 152.8 |
Ca-vO2 | 25.6 |
PH value | 7.56 |
PaO2 | 184 mmHg |
PaCO2 | 33 mmHg |
BE | 2.9 mmol/L |
SaO2 | 100 % |
Blood Lactic Acid Concentration | 2.4 mmol/L |
Oxygenation index (PaO2/FiO2) | 460 mmHg |
PH value | 7.44 |
PcvO2 | 30 mmHg |
PcvCO2 | 42 mmHg |
BE | 2.4 mmol/L |
ScvO2 | 75 % |
Volume of input | 5556 ml |
Volume of output | 2100 ml |
Volume of urine | 800 ml |
Ultrafiltration Volume | 1300 ml |
Norepinephrine Dosage | 48 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | 10 mg |
Levosimendan | no
|
CVP | 12 mmHg |
cardiac output | 5.97 L/min |
cardiac index | 3.29 L/min/m2 |
stroke volume | 62.5 ml |
Stroke Index | 34.5 ml/m2 |
ITBVI | 878 ml/m2 |
GEDVI | 702 ml/m2 |
EVLWI | 6.7 ml/kg |
PVPI | 1.3 |
SVRI | 1970 DSm2/cm5 |
CFI | 5.1 |
GEF | 17 % |
SVV | 10 % |
PPV | % |
dPmax | 1410 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 14 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 1.8 mm |
IVC(expiratory phase) | 2.2 mm |
Respiratory variations of inferior vena cavae diameter | 20 % |
1.9 mm |
|
mm |
|
2.3 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.3 ℃ |
Heart Rate | 93 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 142 mmHg |
Diastolic Pressure | 91 mmHg |
Mean Arterial Pressure | 108 mmHg |
Pcv-aCO2 | 7 mmHg |
DO2 | 467.9 |
VO2 | 109.9 |
Ca-vO2 | 18.5 |
PH value | 7.47 |
PaO2 | 133 mmHg |
PaCO2 | 38 mmHg |
BE | 1 mmol/L |
SaO2 | 99 % |
Blood Lactic Acid Concentration | 1.3 mmol/L |
Oxygenation index (PaO2/FiO2) | 310 mmHg |
PH value | 7.44 |
PcvO2 | 30 mmHg |
PcvCO2 | 41 mmHg |
BE | 303 mmol/L |
ScvO2 | 76 % |
Volume of input | 7147 ml |
Volume of output | 3457 ml |
Volume of urine | 850 ml |
Ultrafiltration Volume | 2657 ml |
Norepinephrine Dosage | 96 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | 30 mg |
Levosimendan |
CVP | 12 mmHg |
cardiac output | 5.95 L/min |
cardiac index | 3.28 L/min/m2 |
stroke volume | 61.2 ml |
Stroke Index | 33.8 ml/m2 |
ITBVI | 875 ml/m2 |
GEDVI | 700 ml/m2 |
EVLWI | 6.6 ml/kg |
PVPI | 1.3 |
SVRI | 2015 DSm2/cm5 |
CFI | 5.0 |
GEF | 17 % |
SVV | 12 % |
PPV | % |
dPmax | 1310 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 10 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 2.0 mm |
IVC(expiratory phase) | 2.4 mm |
Respiratory variations of inferior vena cavae diameter | 18 % |
1.8 mm |
|
mm |
|
2.3 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.5 ℃ |
Heart Rate | 88 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 125 mmHg |
Diastolic Pressure | 65 mmHg |
Mean Arterial Pressure | 85 mmHg |
Pcv-aCO2 | 7 mmHg |
DO2 | 432.7 |
VO2 | 93.2 |
Ca-vO2 | 15.2 |
PH value | 7.45 |
PaO2 | 133 mmHg |
PaCO2 | 38 mmHg |
BE | 2.2 mmol/L |
SaO2 | 99 % |
Blood Lactic Acid Concentration | 1.5 mmol/L |
Oxygenation index (PaO2/FiO2) | 332.5 mmHg |
PH value | 7.39 |
PcvO2 | 30 mmHg |
PcvCO2 | 45 mmHg |
BE | 3.8 mmol/L |
ScvO2 | 78 % |
Volume of input | 10404 ml |
Volume of output | 6117 ml |
Volume of urine | 1080 ml |
Ultrafiltration Volume | 5037 ml |
Norepinephrine Dosage | 96 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | 30 mg |
Levosimendan |
CVP | 8 mmHg |
cardiac output | 6.12 L/min |
cardiac index | 3.38 L/min/m2 |
stroke volume | 63.7 ml |
Stroke Index | 35.1 ml/m2 |
ITBVI | 830 ml/m2 |
GEDVI | 664 ml/m2 |
EVLWI | 6.3 ml/kg |
PVPI | 1.2 |
SVRI | 1930 DSm2/cm5 |
CFI | 5.0 |
GEF | 10 % |
SVV | 11 % |
PPV | % |
dPmax | 1210 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 6 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(expiratory phase) | 1.8 mm |
Respiratory variations of inferior vena cavae diameter | 2.0 % |
IVC(inspiratory phase) | 10 mm |
2.0 mm |
|
mm |
|
2.1 mm |
|
mm |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 1294 pg/ml |
cTNI | ng/ml |
Creatine kinase isoenzyme, CKMB | U/L |
Creatinine | 102 umol/L |
Urea nitrogen | 8 mmol/l |
MDRD | ml/min/1.73m2 |
Date of examination | yyyy-mm-dd |
WBC | 14.3 X10*9/L |
neutrophilic granulocyte percentage | 71.9 % |
Hb | 71 g/L |
CRP | 87.42 mg/L |
Procalcitonin, PCT | 0.975 ng/ml |
Date of test |
|
Sequential Organ Failure Assessment | 13 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 658 pg/ml |
cTNI | ng/ml |
Creatine kinase isoenzyme, CKMB | U/L |
Creatinine | 72 umol/L |
Urea nitrogen | 5.2 mmol/l |
MDRD | ml/min/1.73m2 |
WBC | 10.5 X10*9/L |
neutrophilic granulocyte percentage | 66.8 % |
Hb | 75 g/L |
CRP | 79.62 mg/L |
Procalcitonin, PCT | 1.03 ng/ml |
Sequential Organ Failure Assessment | 13 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 260 pg/ml |
cTNI | ng/ml |
Creatine kinase isoenzyme, CKMB | U/L |
Creatinine | 71 umol/L |
Urea nitrogen | 4.2 mmol/L |
MDRD | ml/min/1.73m2 |
WBC | 8.9 X10*9/L |
neutrophilic granulocyte percentage | 68.3 % |
Hb | 59 g/L |
CRP | 65.71 mg/L |
Procalcitonin, PCT | 1.31 ng/ml |
Sequential Organ Failure Assessment | 11 分 |
Transfusion of Red Cells | |
Transfusion of Red Cells | U |
Plasma infusion | |
Plasma infusion | ml |
platelet transfusion | |
platelet transfusion | U |
APACHEⅡ | 分 |
Complication |
prognosis | |
28-day mortality | |
survival time(day) | 天 |
death time | yyyy/mm/dd |
diagnosis of death |
|
length of stay | 天 |
duration in ICU | 天 |
duration of mechanical ventilation | 小时 |
ICU expenses | 元 |
Continuous Renal Replacement Therapy | |
Continuous Renal Replacement Therapy | 小时 |